20161 ⎘
Medicinal preparations characterised by special physical form; Preparations in capsules, e.g. of gelatin, of chocolate; Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to or , e.g. for obtaining a specific release pattern or for combining different drugs
Oral Pharmaceutical Dosage Form Comprising as Active Ingredients a Proton Pump Inhibitor together with Acetyl Salicyclic Acid
#602Pharmaceutical Compositions for the Coordinated Delivery of Naproxen and Esomeprazole
#603Methods and Compositions for the Treatment of Viral Infections
#604Stable Combinations of Amlodipine Besylate and Benazepril Hydrochloride
#605Pharmaceutical composition
#606Tablet Having Improved Stability With At Least Two Actives
#607Gastric acid secretion inhibiting composition
#608Dry powder fibrin sealant
#609Sustained Release Particulate Oral Dosage Forms of (R)-Baclofen and Methods of Treatment
#610PHARMACEUTICAL COMPOSITIONS OF DICLOFENAC AND MISOPROSTOL
#611Modified Release Famciclovir Compositions
#612Non-abusable pharmaceutical composition comprising opioids
#613Oral multi-functional pharmaceutical capsule preparations of proton pump inhibitors
#614Pharmaceutical compositions comprising entacapone, levodopa, and carbidopa
#615Process For Preparing Solid Dosage Forms of Rosiglitazone Maleate
#616COMPOSITIONS OF 5-HT3 ANTAGONISTS AND DOPAMINE D2 ANTAGONISTS FOR TREATMENT OF DOPAMINE-ASSOCIATED CHRONIC CONDITIONS
#617COMPOSITIONS OF 5-HT3 ANTAGONISTS AND DOPAMINE D2 ANTAGONISTS FOR TREATMENT OF DOPAMINE-ASSOCIATED CHRONIC CONDITIONS
#618TREATING ADHD AND OTHER DISEASES INVOLVING INFLAMMATION
#619Methods and devices for providing prolonged drug therapy
#620MICROCAPSULES HAVING MULTIPLE SHELLS AND METHOD FOR THE PREPARATION THEREOF
#621Dosage Form Comprising Immediate Release Naproxen and Sustained Release Opioid Analgesic
#622Dosage form containing two or more active pharmaceutical ingredients in different physical forms
#623MODIFIED DOSAGE FORMS OF TACROLIMUS
#624DIPYRIDAMOLE AND ACETYLSALICYLIC ACID FORMULATIONS AND PROCESS FOR PREPARING SAME
#625Multiparticulates of spray-coated drug and polymer on a meltable core
#626MULTI-PHASE RELEASE METHSCOPOLAMINE COMPOSITIONS
#627MULTIPARTICULATE FORMULATION HAVING TRAMADOL IN IMMEDIATE AND CONTROLLED RELEASE FORM
#628COMBINED PREPARATION FOR THE TREATMENT OF CARDIOVASCULAR DISEASES BASED ON CHRONOTHERAPY THEORY
#629Method Of Treating Attention Deficit Disorders With D-Threo Methylphenidate
#630Novel acetysalicylic acid formulations
#631Fixed dose pharmaceutical composition comprising hyroxyurea and didanosine
#632COMBINATION OF A TRIPTAN AND AN NSAID
#633Multimicroparticulate Oral Pharmaceutical Form with Modified Release of Angiotensin II Receptor Antagonists
#634Combination preparations of o-acetylsalicylic acid salts
#635SUSTAINED RELEASE OPIOID FORMULATIONS AND METHODS OF USE
#636CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER
#637NOVEL TOPIRAMATE COMPOSITIONS AND AN ESCALATING DOSING STRATEGY FOR TREATING OBESITY AND RELATED DISORDERS
#638DRUG DELIVERY COMPOSITION
#639Escalating dosing regimen for effecting weight loss and treating obesity
#640Pharmaceutical composition
#641Modified Release Loxoprofen Compositions
#642Modified Release Ticlopidine Compositions
#643Oral pharmaceutical dosage forms comprising a proton pump inhibitor and a NSAID
#644Solid oral form provided with a double release profile
#645Multiple Unit Tablets
#646CONTROLLED RELEASE FORMULATIONS OF ALPRAZOLAM
#647Compositions and methods for inhibiting gastric acid secretion using derivatives of small dicarboxylic acids in combination with PPI
#648Dual action, inhaled formulations providing both an immediate and sustained release profile
#649RECONSTITUTABLE MICROSPHERE COMPOSITIONS USEFUL AS ULTRASONIC CONTRAST AGENTS
#650Methods and Medicaments for Administration of Ibuprofen
#651DEXLANSOPRAZOLE COMPOSITIONS
#652STABLE COMBINATIONS OF AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE
#653COMPOSITIONS COMPRISING WEAKLY BASIC DRUGS AND CONTROLLED-RELEASE DOSAGE FORMS
#654Nanoparticulate and Controlled Release Compositions Comprising Prostaglandin Derivatives
#655PHARMACEUTICAL COMPOSITIONS
#656Pharmaceutical Compositions
#657Drug delivery systems comprising weakly basic drugs and organic acids
#658Method and process for the production of multi-coated recognitive and releasing systems
#659Controlled Release Muscarinic Receptor Antagonist Formulation
#660IMPROVED PHARMACOKINETIC PROFILE OF BETA-ADRENERGIC INVERSE AGONISTS FOR THE TREATMENT OF PULMONARY AIRWAY DISEASES
#661Oral dosage forms including an antiplatelet agent and an enterically coated acid inhibitor
#662Porous Drug Delivery Devices and Related Methods
#663Pharmaceutical composition
#664Devices, formulations, and methods for delivery of multiple beneficial agents
#665Extended-release capsules comprising venlafaxine hydrochloride
#666Sustained Release Particulate Oral Dosage Forms of (R) Baclofen and Methods of Treatment
#667Controlled Release Solid Preparation
#668Pharmaceutical safety dosage forms
#669Pharmaceutical compositions
#670Particles for injection and processes for forming the same
#671Zolpidem pharmaceutical compositions
#672Sustained release formulations containing acetaminophen and tramadol
#673Controlled release compositions containing zolpidem
#674Method of manufacturing modified release dosage forms
#675Particles in a capsule
#676Device, System, And Method Comprising Microencapsulated Proton Donor For Release Of Nitric Oxide From A Polymer
#677CARBAMAZEPINE FORMULATIONS
#678Oral extended-release composition
#679Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations
#680Oral Pharmaceutical Form of Losartan
#681Compositions and Methods for Enhancement of Sexual Function
#682CONTROLLED RELEASE SOLID PREPARATION
#683Compositions comprising lipophilic active compounds and method for their preparation
#684Orally disintegrating tablet compositions of lamotrigine
#685NOVEL FORMULATIONS OF PROTON PUMP INHIBITORS AND METHODS OF USING THESE FORMULATIONS
#686Chronic, Bolus Adminstration Of D-Threo Methylphenidate
#687METHODS AND FORMULATIONS FOR CONVERTING INTRAVENOUS AND INJECTABLE DRUGS INTO ORAL DOSAGE FORMS
#688Paliperidone sustained release formulation
#689Sustained release of apo A-I mimetic peptides and methods of treatment
#690Extended release venlafaxine formulation
#691Therapeutic regimens for the treatment of immunoinflammatory disorders
#692Dosage Forms Containing A PPI, NSAID And A Buffer
#693Dosage Forms Containing A PPI, NSAID And A Buffer
#694SOLID CARRIERS FOR IMPROVED DELIVERY OF ACTIVE INGREDIENTS IN PHARMACEUTICAL COMPOSITIONS
#695Pharmaceutical composition comprising lipase inhibitor and lipophilic oil absorbent and oral formulation prepared therefrom
#696BETA-1-SELECTIVE ADRENOCEPTOR BLOCKING AGENT COMPOSITIONS AND METHODS FOR THEIR PREPARATION
#697CARVEDILOL FORMS, COMPOSITIONS, AND METHODS OF PREPARATION THEREOF
#698Composition Containing Anti-Dementia Drug
#699Stabilized tolterodine tartrate formulations
#700Oral pharmaceutical dosage form and manufacturing method thereof
#701Spherical Menthol Particles
#702Ginger Extract For Inhibiting Human Drug Transporters
#703Sustained release micropellets and process for producing the same
#704Pharmaceutical Compositions Containing Mixtures of Polymers and Active Agents Poorly Soluble in Water
#705Once daily formulations of tetracyclines
#706Particulate Compositions Comprising Alginate and/or Alginic Acid
#707Pulsatile release histamine H2 antagonist dosage form
#708Modified release solid or semi-solid dosage forms
#709Tamper-resistant oral opioid agonist formulations
#710Tamper-resistant oral opioid agonist formulations
#711Tamper-resistant oral opioid agonist formulations
#712Method of administering testosterone
#713Tamper-resistant oral opioid agonist formulations
#714SUSTAINED RELEASE ORAL FORMULATION AND PROCESS FOR THE PREPARATION THEREOF
#715Polymer Composition And Dosage Forms Comprising The Same
#716Storage-Stable Oral Dosage Form of Amoxicillin and Clavulanic Acid
#717Dosage forms for movement disorder treatment
#718CONTROLLED RELEASE DOPAMINE AGONIST COMPOSITIONS
#719Controlled-Release Flupirtine Compositions, Compacts, Kits and Methods of Making and Use Thereof
#720Controlled-Release Flupirtine Compositions, Compacts, Kits and Methods of Making and Use Thereof
#721Nanoparticulate and controlled release compositions comprising cefditoren
#722Controlled Release Compositions Comprising an Antipsychotic Agent
#723Ppar-Gamma Agonists for Improvement of Cognitive Function in Apoe4 Negative Patients
#724SUSTAINED RELEASE COMPOSITIONS OF DRUGS
#725Microencapsules Containing Surface-Modified Microparticles And Methods Of Forming And Using The Same
#726Compositions and methods for inhibiting gastric acid secretion
#727Pharmaceutical compositions
#728Gel Composition Comprising Charged Polymers
#729Combination of Rosiglitazone and Donepezil for Improvement of Cognitive Function
#730Method and process for the production of multi-coated recognitive and releasing systems
#731MULTIPARTICULATE CONTROLLED RELEASE SELECTIVE SEROTONIN REUPTAKE INHIBITOR FORMULATIONS
#732ABUSE-DETERRENT PHARMACEUTICAL COMPOSITIONS OF OPIOIDS AND OTHER DRUGS
#733Pharmaceutical compositions of amlodipine and benazepril
#734Solid, Oral Drug Form Which Has Been Designed to Prevent Misuse
#735Composition
#736Extended-release dosage form
#737Dosage forms for administering combinations of drugs
#738Controlled release compositions comprising Nimesulide
#739CLONIDINE COMPOSITION AND METHOD OF USE
#740Methods and compositions for deterring abuse of orally administered pharmaceutical products
#741Oral Dosage Form Comprising Rosiglitazone
#742Modified release dosage forms of amoxicillin
#743Time-sustained-release formulations comprising a beta-blocker
#744Dosage forms for movement disorder treatment
#745Nanoparticulate and controlled release compositions comprising cyclosporine
#746Modified release analgesic suspensions
#747Sustained-release formulations of topiramate
#748Modified Release of Compositions Containing a Combination of Carbidopa, Levodopa and Entacapone
#749Pharmaceutical compositions comprising a combination of piperidinoalkanol and decongestant
#750Minicapsule Formulations
#751COMPOSITIONS COMPRISING NANOPARTICULATE NAPROXEN AND CONTROLLED RELEASE HYDROCODONE
#752COMPOSITIONS COMPRISING BETA-ADRENERGIC RECEPTOR ANTAGONISTS AND DIURETICS
#753COMPOSITIONS COMPRISING NANOPARTICULATE MELOXICAM AND CONTROLLED RELEASE HYDROCODONE
#754Active Substance Delivery System Comprising A Hydrogel Atrix And Microcarriers
#755SUSTAINED RELEASE PHARMACEUTICAL COMPOSITIONS OF VENLAFAXINE AND PROCESS FOR PREPARATION THEREOF
#756Dosage forms for tamper prone therapeutic agents
#757Preparation and administration form comprising an acid-labile active compound
#758Controlled Release Compositions Comprising a Cephalosporin for the Treatment of a Bacterial Infection
#759Multi-Phase Release Methscopolamine Compositions
#760Methods and medicaments for administration of ibuprofen
#761Acetaminophen pharmaceutical compositions
#762Controlled release formulation of tolterodine
#763Pharmaceutical compositions of ilaparazole
#764Combined Pharmaceutical Formulation with Controlled-Release Comprising Dihydropyridine Calcium Channel Blockers and HMG-COA Reductase Inhibitors
#765Pharmaceutical compositions and methods for improved bacterial eradication
#766Sustained-release bupropion and bupropion/mecamylamine tablets
#767Gastric acid secretion inhibiting composition
#768SUSTAINED RELEASE MONOEXIMIC FORMULATIONS OF OPIOID AND NONOPIOID ANALGESICS
#769Antibiotic-Based Pharmaceutical Formulation in Microcapsular Form
#770Capsule containing granular pharmaceutical compositions
#771Combination Products
#772Pharmaceutical Compositions Comprising (+)-(2S,3S)-2-(3-Chlorophenyl)-3,5,5-Trimethyl-2-Morpholinol
#773Oral dosage form comprising an antimisuse system
#774COMPOSITIONS OF 5-HT3 ANTAGONISTS AND DOPAMINE D2 ANTAGONISTS FOR TREATMENT OF DOPAMINE-ASSOCIATED CHRONIC CONDITIONS
#775Compositions of 5-HT3 antagonists and dopamine D2 antagonists for treatment of dopamine-associated chronic conditions
#776Controlled Release Compositions Comprising Levetiracetam
#777Dihydropyrimidine Formulations
#778Anti-inflammatory and analgesic compositions and related methods
#779Sustained release formulations of opioid and nonopioid analgesics
#780Composition and use
#781Methods and compositions for the treatment of viral infections
#782Tamper Resistant Co-Extruded Dosage Form Containing An Active Agent And An Adverse Agent And Process Of Making Same
#783Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations
#784ANTIBIOTIC FORMULATION AND METHOD OF TREATMENT
#785Oral Dosage Formulations and Methods of Preparing the Same
#786Dosage Forms Containing A PPI, NSAID, and Buffer
#787Oral Dosage Formulations and Methods of Preparing the Same
#788Oral dosage forms including an antiplatelet agent and an acid inhibitor
#789Formulation comprising histone deacetylase inhibitors
#790Methods and compositions for deterring abuse of orally administered pharmaceutical products
#791High Pressure Compaction For Pharmaceutical Formulations
#792Tamper resistant dosage form comprising an adsorbent and an adverse agent
#793DUAL-RELEASE COMPOSITIONS OF A CYCLOOXYGENASE-2 INHIBITOR
#794EXTENDED RELEASE PHARMACEUTICAL COMPOSITIONS
#795SOLID-STATE FORM OF CELECOXIB HAVING ENHANCED BIOAVAILABILITY
#796Pharmaceutical formulations for dry powder inhalers comprising a low-dosage strength active ingredient
#797Oral dosage form comprising an antimisuse system
#798DRUG DELIVERY SYSTEMS COMPRISING WEAKLY BASIC DRUGS AND ORGANIC ACIDS
#799Taste-masked drugs in rupturing multiparticulates
#800Pantoprazole multiparticulate formulations
#801Pantoprazole multiparticulate formulations
#802DRUG DELIVERY SYSTEMS COMPRISING WEAKLY BASIC SELECTIVE SEROTONIN 5-HT3 BLOCKING AGENT AND ORGANIC ACIDS
#803Dipyridamole extended-release formulations and process for preparing same
#804Pharmaceutical formulations of oxcarbazepine and methods for its preparation
#805Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
#806Nanoparticulate and controlled release compositions comprising a cephalosporin
#807Parathyroid hormone (pth) containing pharmaceutical compositions for oral use
#808Gastric release pulse system for drug delivery
#809Oral pharmaceutical formulations containing non-steroidal anti-inflammatory drugs and acid inhibitors
#810COMPOSITIONS AND METHODS FOR DELIVERY OF PROTEINS AND ADJUVANTS ENCAPSULATED IN MICROSPHERES
#811Solid ganaxolone formulations and methods for the making and use thereof
#812Dosage forms for movement disorder treatment
#813SUSTAINED-RELEASE FORMULATION OF ZONISAMIDE
#814Liquid ganaxolone formulations and methods for the making and use thereof
#815SEQUENTIAL RELEASE PHARMACEUTICAL FORMULATIONS
#816Solid compositions of low-solubility drugs and poloxamers
#817MODIFIED AND PULSATILE RELEASE PHARMACEUTICAL FORMULATIONS OF ESCITALOPRAM
#818Controlled release compositions comprising nimesulide
#819Multi-functional microcapsules and method and device for manufacturing same
#820Modified Release Compositions Comprising a Fluorocytidine Derivative for the Treatment of Cancer
#821Extended release composition containing tramadol
#822New Combination Dosage Form
#823Controlled release compositions comprising a combination of isosorbide dinitrate and hydralazine hydrochrloride
#824Controlled release compositions comprising a combination of isosorbide dinitrate and hydralazine hydrochloride
#825Co-formulations or kits of bioactive agents
#826GALANTAMINE COMPOSITIONS
#827Stable combinations of amlodipine besylate and benazepril hydrochloride
#828MODIFIED AND IMMEDIATE RELEASE FORMULATIONS OF MEMANTINE
#829Tamper resistant dosage form comprising co-extruded, sequestered adverse agent particles and process of making same
#830Method of preparing mixed formulation of sustained release microspheres by continuous one-step process
#831Sustained release oral formulations
#832Stable drug form for oral administration with benzimidazole derivatives as active ingredient and process for the preparation thereof
#833Medicaments containing famotidine and ibuprofen and administration of same
#834Unit dose form with ibuprofen-famotidine admixture
#835Methods and compositions using gonadotropin hormone releasing hormone
#836Pantoprazole multiparticulate formulations
#837Pharmaceutical compositions
#838Diltiazem controlled release formulation and method of manufacture
#839Stable topiramate formulations
#840Gastric acid secretion inhibiting composition
#841COMPOSITIONS AND METHODS FOR CONTROLLING ABUSE OF MEDICATIONS
#842Dosage forms for movement disorder treatment
#843Coated particles for sustained-release pharmaceutical administration
#844Nanoparticulate clopidogrel and aspirin combination formulations
#845Timed, sustained release systems for propranolol
#846Controlled release compositions comprising an acylanilide
#847Controlled release formulations of opioid and nonopioid analgesics
#848SYSTEMS, METHODS AND APPARATUSES FOR MANUFACTURING DOSAGE FORMS
#849Timed, pulsatile release systems
#850Oral controlled release formulations
#851Multiparticulate modified release composition
#852O-desmethylvenlafaxine and bazedoxifene combination product and uses thereof
#853Controlled release compositions of gamma-hydroxybutyrate
#854In situ controlled release drug delivery system
#855Dosage form and method for sustained release of substituted pyrazine compound
#856Sequestered antagonist formulations
#857Oral compositions for the stimulation of gastric acid secretion comprising pentagastrin
#858Dosage form for treating gastrointestinal disorders
#859Pharmaceutical composition for controlled release of beta-lactam antibiotics in combination with beta-lactamase inhibitors
#860Method to obtain microparticles containing an H+,K+-ATP-ASE inhibitor
#861Timed dual release dosage forms comprising a short acting hypnotic or a salt thereof
#862Controlled release preparations comprising tramadol and topiramate
#863Leukotriene and integrin inhibitor combination and treatment method
#864Oral compositions for treatment of diseases
#865Controlled release composition
#866Preparation and administration form comprising an acid-labile active compound
#867Topiramate pharmaceutical composition
#868Therapeutic system comprising amoxicillin and clavulanic acid
#869Gastric acid secretion inhibiting composition
#870Pharmaceutical compositions
#871Material encapsulation system
#872Antiviral product, use and formulation thereof
#873Pharmaceutical compositions
#874Method of providing customized drug delivery systems
#875Pharmaceutical compositions comprising a basic drug compound, a surfactant, and a physiologically tolerable water soluble acid
#876Method of drug delivery to interstitial regions of the myocardium
#877Process of manufacture of novel drug delivery system: multilayer tablet composition of thiazolidinedione and biguanides
#878Compositions and methods for enhancing analgesic potency of tramadol and attenuating its adverse side effects
#879Controlled regional oral delivery
#880Multiparticulate formulations of lithium salts for oral administration suitable for once-a-day administration
#881Tamper-resistant oral opioid agonist formulations
#882Means of delivering drugs in an ascending zero order release pattern
#883Tumor targeting drug-loaded particles
#884Method of treating attention deficit disorders with d-threo methylphenidate
#885Antidiabetic preparation for oral administration
#886Method of drug delivery to interstitial regions of the myocardium
#887Solid oral dosage form containing seamless microcapsules
#888Tablet for pulsed delivery
#889Nitrofurantoin controlled release dosage form
#890Sustained release formulations of guaifenesin and additional drug ingredients
#891Solid-state form of celecoxib having enhanced bioavailability
#892Modified release dosage forms
#893Process for making aqueous coated beadlets
#894Pharmaceutical compositions for the coordinated delivery of NSAIDs
#895Combination of proton pump inhibitor, buffering agent, and nonsteroidal anti-inflammatory drug
#896Controlled-release sedative-hypnotic compositions and methods related thereto
#897Anti-fungal composition
#898Methods and devices for providing prolonged drug therapy
#899Pharmaceutical dosage forms having immediate release and/or controlled release properties that contain a GABAB receptor agonist
#900Pharmaceutical dosage forms having immediate release and controlled release properties that contain a GABAB receptor agonist